Hendrick Health System — Abilene, Texas

Hendrick Health System is a clinical research site located in Abilene, Texas, United States 79601.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Hendrick Health System has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Triple Negative Breast Cancer, Extensive Stage Small Cell Lung Cancer (ES-SCLC).

Sponsors: Gilead Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Abilene

Browse all research sites in Texas · View every site in Abilene

• Retina Research Institute of Texas
• Hendrick Medical Center
• Texas Oncology West Texas
• Texas Oncology-Abilene
• Retina Res Institute of Texas
• Texas Cancer Center/Abilene
• Texas Cancer Center
• Hendrick Cancer Center
• Hendrick Health
• West Texas Retina Consultants P.A.
• Velocity Clinical Research Abilene
• Novartis Investigative Site

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hendrick Health System?

Hendrick Health System has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hendrick Health System conducted?

Hendrick Health System has 2 clinical trials on record, with 2 currently active. Their work covers Triple Negative Breast Cancer, Extensive Stage Small Cell Lung Cancer (ES-SCLC).

Is Hendrick Health System accredited by Crixeo Clinical Trials?

Hendrick Health System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hendrick Health System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.